Overview

Cell Viability Assays Market Introduction:

Cell Viability Assays Market is estimated to value over USD 5.5 billion by 2028 end and register CAGR of over 7.5% by 2028 end.

Cell viability assays are technologies that are used for determining the cell strength in response to any tested drug. They are generally tested on a tissue, cell or an organ. Cell viability looks for the cells to identify any inorganic reaction which they aren’t supposed to follow and scale this reaction to mark its viability. This plays an important role in all forms of cell culture. Cell viability forms the basis of an assay to look out for drug effectiveness or cell viability with multiple combined particles and it also offers different characteristics of cell health to the user.

Cell viability assay is primarily performed in all in vitro and pharmaceutical studies due to increased applications of cell viability assays for drug screening. A large number of local manufacturers have expanded their cell viability assay kits product portfolio to determine effects in cell growth and cell death for the sake of clinical research and this has increased the demand for cell viability assays thus aiding the cell viability assays market size proliferation.

Key market players include:
Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, GE Healthcare, Danaher Corporation, Becton, Dickinson and Company, Promega Corporation, Biotium, Abcam PLC, Creative Bioarray, Biotek Instruments, Perkinelmer.

Cell Viability Assays Market Segmentation:

By Product
• Consumables
o Reagents
o Assay Kits
• Tetrazolium Reduction Assay Kits
o Mtt Assay Kits
o Other Tetrazolium Assay Kits
• Resazurin Cell Viability Assay Kits
• Calcein-Am Cell Viability Assay Kits
• Other Assay Kits
o Microplates
• Instruments
o Automated Cell Counters
o Flow Cytometers
o Spectrophometers
o Cell Imaging & Analysis Systems

By Cell Type

Human Cells
Animal Cells
Microbial Cells

By Application

Drug Discovery and Development
Basic Research
Stem Cell Research
Clinical and Diagnostic Applications
Other Applications

By End User

Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Hospital & Diagnostic Laboratories
Other End Users

By Region

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Competitive Landscape:

Tier 1 players- established companies in the market with a major market share
Tier 2 players
Emerging players which are growing rapidly
New Entrants

FutureWise Key Takeaways:

Growth prospects
SWOT analysis
Key trends
Key data-points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the global cell viability assays market by product, by cell type, by application, by end user and by region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Latin America and Middle East & Africa
To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization Mobility Care offered are free of charge with purchase of any license of the report
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com